Clinical Trial Update: Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and efficacy study of Mix Vaccine in prostate cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Mix Vaccine

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Prostatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED